Pantoprazol Serraclinics (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Serraclinics, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and adolescents. GNH USA supplies Pantoprazol Serraclinics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Serraclinics is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for: - Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis. - Erosive duodenal ulcer: promotes healing of ulcers in the duodenum. - Zollinger‑Ellison syndrome: controls the excess gastric acid production associated with the condition. - Helicobacter pili infection associated ulcers and erosive oes  g ?  g  t ? 

Pantoptablet  

Common  t  : -   t